Clearside Biomedical
Alpharetta
About Clearside Biomedical
Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing drugs to distinct eye tissues, such as the retina, trabecular meshwork, and corneal stroma. The company’s CLS1001 is under development for retinal applications through the delivery of therapeutics to the suprachoroidal space. Clearside BioMedical was incorporated in 2011 and is based in Atlanta, Georgia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $203.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2024)
- Ticker: nasdaq:CLSD
- Website: clearsidebio.com
- Phone: (678)270-3631
Industries & Categories
Biotechnology, Health Care, Medical Device, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/clearside-biomedical-142957 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.